RebrAIn

About:

RebrAIn provides a targeted technology for planning neurosurgical procedures.

Website: https://rebrain.eu/en

Top Investors: Karista, NACO

Description:

RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target location for electrode surgical insertion with the use of this SaaS service. Its innovative method predicts the treatment zone in each patient's brain using machine learning clinical patient data.

Total Funding Amount:

3.7M EUR

Headquarters Location:

Pessac, Aquitaine, France

Founded Date:

2021-01-01

Contact Email:

contact(AT)rebrain.eu

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-03-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai